id	sid	tid	token	lemma	pos
cord-339444-f8lfob47	1	1	key	key	NNP
cord-339444-f8lfob47	1	2	:	:	:
cord-339444-f8lfob47	1	3	cord-339444-f8lfob47	cord-339444-f8lfob47	NN
cord-339444-f8lfob47	1	4	authors	author	NNS
cord-339444-f8lfob47	1	5	:	:	:
cord-339444-f8lfob47	1	6	Bigna	Bigna	NNP
cord-339444-f8lfob47	1	7	,	,	,
cord-339444-f8lfob47	1	8	Jean	Jean	NNP
cord-339444-f8lfob47	1	9	Joel	Joel	NNP
cord-339444-f8lfob47	1	10	;	;	:
cord-339444-f8lfob47	1	11	Kamtchum	Kamtchum	NNP
cord-339444-f8lfob47	1	12	-	-	HYPH
cord-339444-f8lfob47	1	13	Tatuene	Tatuene	NNP
cord-339444-f8lfob47	1	14	,	,	,
cord-339444-f8lfob47	1	15	Joseph	Joseph	NNP
cord-339444-f8lfob47	1	16	;	;	:
cord-339444-f8lfob47	1	17	Noubiap	Noubiap	NNP
cord-339444-f8lfob47	1	18	,	,	,
cord-339444-f8lfob47	1	19	Jean	Jean	NNP
cord-339444-f8lfob47	1	20	Jacques	Jacques	NNP
cord-339444-f8lfob47	1	21	title	title	NN
cord-339444-f8lfob47	1	22	:	:	:
cord-339444-f8lfob47	1	23	Claims	claim	NNS
cord-339444-f8lfob47	1	24	about	about	IN
cord-339444-f8lfob47	1	25	the	the	DT
cord-339444-f8lfob47	1	26	safety	safety	NN
cord-339444-f8lfob47	1	27	and	and	CC
cord-339444-f8lfob47	1	28	efficacy	efficacy	NN
cord-339444-f8lfob47	1	29	of	of	IN
cord-339444-f8lfob47	1	30	early	early	JJ
cord-339444-f8lfob47	1	31	treatment	treatment	NN
cord-339444-f8lfob47	1	32	of	of	IN
cord-339444-f8lfob47	1	33	COVID-19	COVID-19	NNP
cord-339444-f8lfob47	1	34	with	with	IN
cord-339444-f8lfob47	1	35	hydroxychloroquine	hydroxychloroquine	NNP
cord-339444-f8lfob47	1	36	and	and	CC
cord-339444-f8lfob47	1	37	azithromycin	azithromycin	NNP
cord-339444-f8lfob47	1	38	must	must	MD
cord-339444-f8lfob47	1	39	be	be	VB
cord-339444-f8lfob47	1	40	supported	support	VBN
cord-339444-f8lfob47	1	41	by	by	IN
cord-339444-f8lfob47	1	42	real	real	JJ
cord-339444-f8lfob47	1	43	evidence	evidence	NN
cord-339444-f8lfob47	1	44	date	date	NN
cord-339444-f8lfob47	1	45	:	:	:
cord-339444-f8lfob47	1	46	2020	2020	CD
cord-339444-f8lfob47	1	47	-	-	HYPH
cord-339444-f8lfob47	1	48	09	09	CD
cord-339444-f8lfob47	1	49	-	-	SYM
cord-339444-f8lfob47	1	50	25	25	CD
cord-339444-f8lfob47	1	51	journal	journal	NN
cord-339444-f8lfob47	1	52	:	:	:
cord-339444-f8lfob47	2	1	Travel	travel	VB
cord-339444-f8lfob47	2	2	Med	Med	NNP
cord-339444-f8lfob47	2	3	Infect	infect	VBP
cord-339444-f8lfob47	2	4	Dis	dis	NN
cord-339444-f8lfob47	2	5	DOI	doi	NN
cord-339444-f8lfob47	2	6	:	:	:
cord-339444-f8lfob47	2	7	10.1016/	10.1016/	CD
cord-339444-f8lfob47	3	1	j.tmaid.2020.101886	j.tmaid.2020.101886	NNP
cord-339444-f8lfob47	3	2	sha	sha	NNP
cord-339444-f8lfob47	3	3	:	:	:
cord-339444-f8lfob47	4	1	c5cd5cd6e3d714e38d92731867aa0c8903dc6ad1	c5cd5cd6e3d714e38d92731867aa0c8903dc6ad1	NNP
cord-339444-f8lfob47	4	2	doc_id	doc_id	CD
cord-339444-f8lfob47	4	3	:	:	:
cord-339444-f8lfob47	4	4	339444	339444	CD
cord-339444-f8lfob47	4	5	cord_uid	cord_uid	NNS
cord-339444-f8lfob47	4	6	:	:	:
cord-339444-f8lfob47	5	1	f8lfob47	f8lfob47	NNP
cord-339444-f8lfob47	5	2	nan	nan	NNP
cord-339444-f8lfob47	6	1	Based	base	VBN
cord-339444-f8lfob47	6	2	on	on	IN
cord-339444-f8lfob47	6	3	data	datum	NNS
cord-339444-f8lfob47	6	4	from	from	IN
cord-339444-f8lfob47	6	5	1061	1061	CD
cord-339444-f8lfob47	6	6	COVID-19	covid-19	CD
cord-339444-f8lfob47	6	7	patients	patient	NNS
cord-339444-f8lfob47	6	8	(	(	-LRB-
cord-339444-f8lfob47	6	9	94.7	94.7	CD
cord-339444-f8lfob47	6	10	%	%	NN
cord-339444-f8lfob47	6	11	symptomatic	symptomatic	JJ
cord-339444-f8lfob47	6	12	,	,	,
cord-339444-f8lfob47	6	13	85.7	85.7	CD
cord-339444-f8lfob47	6	14	%	%	NN
cord-339444-f8lfob47	6	15	outpatients	outpatient	NNS
cord-339444-f8lfob47	6	16	)	)	-RRB-
cord-339444-f8lfob47	6	17	,	,	,
cord-339444-f8lfob47	6	18	the	the	DT
cord-339444-f8lfob47	6	19	authors	author	NNS
cord-339444-f8lfob47	6	20	concluded	conclude	VBD
cord-339444-f8lfob47	6	21	that	that	IN
cord-339444-f8lfob47	6	22	early	early	JJ
cord-339444-f8lfob47	6	23	treatment	treatment	NN
cord-339444-f8lfob47	6	24	of	of	IN
cord-339444-f8lfob47	6	25	COVID-19	COVID-19	NNP
cord-339444-f8lfob47	6	26	(	(	-LRB-
cord-339444-f8lfob47	6	27	before	before	IN
cord-339444-f8lfob47	6	28	complications	complication	NNS
cord-339444-f8lfob47	6	29	occur	occur	VBP
cord-339444-f8lfob47	6	30	)	)	-RRB-
cord-339444-f8lfob47	6	31	with	with	IN
cord-339444-f8lfob47	6	32	the	the	DT
cord-339444-f8lfob47	6	33	combination	combination	NN
cord-339444-f8lfob47	6	34	of	of	IN
cord-339444-f8lfob47	6	35	hydroxychloroquine	hydroxychloroquine	NN
cord-339444-f8lfob47	6	36	and	and	CC
cord-339444-f8lfob47	6	37	azithromycin	azithromycin	NNP
cord-339444-f8lfob47	6	38	(	(	-LRB-
cord-339444-f8lfob47	6	39	HCQ+AZ	HCQ+AZ	NNP
cord-339444-f8lfob47	6	40	)	)	-RRB-
cord-339444-f8lfob47	6	41	"	"	``
cord-339444-f8lfob47	6	42	is	be	VBZ
cord-339444-f8lfob47	6	43	safe	safe	JJ
cord-339444-f8lfob47	6	44	and	and	CC
cord-339444-f8lfob47	6	45	associated	associate	VBN
cord-339444-f8lfob47	6	46	with	with	IN
cord-339444-f8lfob47	6	47	very	very	RB
cord-339444-f8lfob47	6	48	low	low	JJ
cord-339444-f8lfob47	6	49	fatality	fatality	NN
cord-339444-f8lfob47	6	50	rate	rate	NN
cord-339444-f8lfob47	6	51	"	"	''
cord-339444-f8lfob47	6	52	[	[	-LRB-
cord-339444-f8lfob47	6	53	1	1	CD
cord-339444-f8lfob47	6	54	]	]	-RRB-
cord-339444-f8lfob47	6	55	.	.	.
cord-339444-f8lfob47	7	1	This	this	DT
cord-339444-f8lfob47	7	2	claim	claim	NN
cord-339444-f8lfob47	7	3	is	be	VBZ
cord-339444-f8lfob47	7	4	not	not	RB
cord-339444-f8lfob47	7	5	supported	support	VBN
cord-339444-f8lfob47	7	6	by	by	IN
cord-339444-f8lfob47	7	7	the	the	DT
cord-339444-f8lfob47	7	8	data	datum	NNS
cord-339444-f8lfob47	7	9	presented	present	VBN
cord-339444-f8lfob47	7	10	in	in	IN
cord-339444-f8lfob47	7	11	their	-PRON-	PRP$
cord-339444-f8lfob47	7	12	article	article	NN
cord-339444-f8lfob47	7	13	and	and	CC
cord-339444-f8lfob47	7	14	is	be	VBZ
cord-339444-f8lfob47	7	15	,	,	,
cord-339444-f8lfob47	7	16	therefore	therefore	RB
cord-339444-f8lfob47	7	17	,	,	,
cord-339444-f8lfob47	7	18	misleading	mislead	VBG
cord-339444-f8lfob47	7	19	.	.	.
cord-339444-f8lfob47	8	1	Indeed	indeed	RB
cord-339444-f8lfob47	8	2	,	,	,
cord-339444-f8lfob47	8	3	in	in	IN
cord-339444-f8lfob47	8	4	the	the	DT
cord-339444-f8lfob47	8	5	absence	absence	NN
cord-339444-f8lfob47	8	6	of	of	IN
cord-339444-f8lfob47	8	7	a	a	DT
cord-339444-f8lfob47	8	8	control	control	NN
cord-339444-f8lfob47	8	9	group	group	NN
cord-339444-f8lfob47	8	10	of	of	IN
cord-339444-f8lfob47	8	11	patients	patient	NNS
cord-339444-f8lfob47	8	12	who	who	WP
cord-339444-f8lfob47	8	13	did	do	VBD
cord-339444-f8lfob47	8	14	not	not	RB
cord-339444-f8lfob47	8	15	receive	receive	VB
cord-339444-f8lfob47	8	16	HCQ+AZ	HCQ+AZ	NNP
cord-339444-f8lfob47	8	17	,	,	,
cord-339444-f8lfob47	8	18	it	-PRON-	PRP
cord-339444-f8lfob47	8	19	is	be	VBZ
cord-339444-f8lfob47	8	20	inappropriate	inappropriate	JJ
cord-339444-f8lfob47	8	21	to	to	TO
cord-339444-f8lfob47	8	22	conclude	conclude	VB
cord-339444-f8lfob47	8	23	that	that	IN
cord-339444-f8lfob47	8	24	this	this	DT
cord-339444-f8lfob47	8	25	therapeutic	therapeutic	JJ
cord-339444-f8lfob47	8	26	combination	combination	NN
cord-339444-f8lfob47	8	27	was	be	VBD
cord-339444-f8lfob47	8	28	associated	associate	VBN
cord-339444-f8lfob47	8	29	with	with	IN
cord-339444-f8lfob47	8	30	low	low	JJ
cord-339444-f8lfob47	8	31	fatality	fatality	NN
cord-339444-f8lfob47	8	32	rate	rate	NN
cord-339444-f8lfob47	8	33	.	.	.
cord-339444-f8lfob47	9	1	This	this	DT
cord-339444-f8lfob47	9	2	is	be	VBZ
cord-339444-f8lfob47	9	3	a	a	DT
cord-339444-f8lfob47	9	4	major	major	JJ
cord-339444-f8lfob47	9	5	concern	concern	NN
cord-339444-f8lfob47	9	6	,	,	,
cord-339444-f8lfob47	9	7	especially	especially	RB
cord-339444-f8lfob47	9	8	because	because	IN
cord-339444-f8lfob47	9	9	spontaneous	spontaneous	JJ
cord-339444-f8lfob47	9	10	clearance	clearance	NN
cord-339444-f8lfob47	9	11	of	of	IN
cord-339444-f8lfob47	9	12	SARS	SARS	NNP
cord-339444-f8lfob47	9	13	-	-	HYPH
cord-339444-f8lfob47	9	14	CoV-2	CoV-2	NNP
cord-339444-f8lfob47	9	15	infection	infection	NN
cord-339444-f8lfob47	9	16	is	be	VBZ
cord-339444-f8lfob47	9	17	more	more	RBR
cord-339444-f8lfob47	9	18	common	common	JJ
cord-339444-f8lfob47	9	19	in	in	IN
cord-339444-f8lfob47	9	20	younger	young	JJR
cord-339444-f8lfob47	9	21	individuals	individual	NNS
cord-339444-f8lfob47	9	22	who	who	WP
cord-339444-f8lfob47	9	23	seem	seem	VBP
cord-339444-f8lfob47	9	24	to	to	TO
cord-339444-f8lfob47	9	25	represent	represent	VB
cord-339444-f8lfob47	9	26	the	the	DT
cord-339444-f8lfob47	9	27	majority	majority	NN
cord-339444-f8lfob47	9	28	of	of	IN
cord-339444-f8lfob47	9	29	the	the	DT
cord-339444-f8lfob47	9	30	study	study	NN
cord-339444-f8lfob47	9	31	cohort	cohort	NN
cord-339444-f8lfob47	9	32	[	[	-LRB-
cord-339444-f8lfob47	9	33	2	2	CD
cord-339444-f8lfob47	9	34	]	]	-RRB-
cord-339444-f8lfob47	9	35	.	.	.
cord-339444-f8lfob47	10	1	The	the	DT
cord-339444-f8lfob47	10	2	authors	author	NNS
cord-339444-f8lfob47	10	3	do	do	VBP
cord-339444-f8lfob47	10	4	not	not	RB
cord-339444-f8lfob47	10	5	provide	provide	VB
cord-339444-f8lfob47	10	6	a	a	DT
cord-339444-f8lfob47	10	7	rationale	rationale	NN
cord-339444-f8lfob47	10	8	for	for	IN
cord-339444-f8lfob47	10	9	the	the	DT
cord-339444-f8lfob47	10	10	decision	decision	NN
cord-339444-f8lfob47	10	11	not	not	RB
cord-339444-f8lfob47	10	12	to	to	TO
cord-339444-f8lfob47	10	13	consider	consider	VB
cord-339444-f8lfob47	10	14	a	a	DT
cord-339444-f8lfob47	10	15	control	control	NN
cord-339444-f8lfob47	10	16	group	group	NN
cord-339444-f8lfob47	10	17	.	.	.
cord-339444-f8lfob47	11	1	This	this	DT
cord-339444-f8lfob47	11	2	is	be	VBZ
cord-339444-f8lfob47	11	3	a	a	DT
cord-339444-f8lfob47	11	4	fundamental	fundamental	JJ
cord-339444-f8lfob47	11	5	methodological	methodological	JJ
cord-339444-f8lfob47	11	6	point	point	NN
cord-339444-f8lfob47	11	7	that	that	WDT
cord-339444-f8lfob47	11	8	would	would	MD
cord-339444-f8lfob47	11	9	help	help	VB
cord-339444-f8lfob47	11	10	to	to	TO
cord-339444-f8lfob47	11	11	support	support	VB
cord-339444-f8lfob47	11	12	the	the	DT
cord-339444-f8lfob47	11	13	argument	argument	NN
cord-339444-f8lfob47	11	14	for	for	IN
cord-339444-f8lfob47	11	15	a	a	DT
cord-339444-f8lfob47	11	16	causal	causal	JJ
cord-339444-f8lfob47	11	17	link	link	NN
cord-339444-f8lfob47	11	18	between	between	IN
cord-339444-f8lfob47	11	19	early	early	JJ
cord-339444-f8lfob47	11	20	HCQ+AZ	HCQ+AZ	NNP
cord-339444-f8lfob47	11	21	therapy	therapy	NN
cord-339444-f8lfob47	11	22	and	and	CC
cord-339444-f8lfob47	11	23	good	good	JJ
cord-339444-f8lfob47	11	24	clinical	clinical	JJ
cord-339444-f8lfob47	11	25	outcomes	outcome	NNS
cord-339444-f8lfob47	11	26	.	.	.
cord-339444-f8lfob47	12	1	Furthermore	furthermore	RB
cord-339444-f8lfob47	12	2	,	,	,
cord-339444-f8lfob47	12	3	their	-PRON-	PRP$
cord-339444-f8lfob47	12	4	safety	safety	NN
cord-339444-f8lfob47	12	5	data	datum	NNS
cord-339444-f8lfob47	12	6	are	be	VBP
cord-339444-f8lfob47	12	7	also	also	RB
cord-339444-f8lfob47	12	8	not	not	RB
cord-339444-f8lfob47	12	9	generalizable	generalizable	JJ
cord-339444-f8lfob47	12	10	because	because	IN
cord-339444-f8lfob47	12	11	they	-PRON-	PRP
cord-339444-f8lfob47	12	12	are	be	VBP
cord-339444-f8lfob47	12	13	more	more	RBR
cord-339444-f8lfob47	12	14	likely	likely	JJ
cord-339444-f8lfob47	12	15	to	to	TO
cord-339444-f8lfob47	12	16	be	be	VB
cord-339444-f8lfob47	12	17	driven	drive	VBN
cord-339444-f8lfob47	12	18	by	by	IN
cord-339444-f8lfob47	12	19	the	the	DT
cord-339444-f8lfob47	12	20	specific	specific	JJ
cord-339444-f8lfob47	12	21	demographic	demographic	JJ
cord-339444-f8lfob47	12	22	and	and	CC
cord-339444-f8lfob47	12	23	clinical	clinical	JJ
cord-339444-f8lfob47	12	24	characteristics	characteristic	NNS
cord-339444-f8lfob47	12	25	of	of	IN
cord-339444-f8lfob47	12	26	the	the	DT
cord-339444-f8lfob47	12	27	population	population	NN
cord-339444-f8lfob47	12	28	.	.	.
cord-339444-f8lfob47	13	1	Indeed	indeed	RB
cord-339444-f8lfob47	13	2	,	,	,
cord-339444-f8lfob47	13	3	with	with	IN
cord-339444-f8lfob47	13	4	a	a	DT
cord-339444-f8lfob47	13	5	mean	mean	JJ
cord-339444-f8lfob47	13	6	age	age	NN
cord-339444-f8lfob47	13	7	of	of	IN
cord-339444-f8lfob47	13	8	only	only	RB
cord-339444-f8lfob47	13	9	43.6	43.6	CD
cord-339444-f8lfob47	13	10	years	year	NNS
cord-339444-f8lfob47	13	11	,	,	,
cord-339444-f8lfob47	13	12	the	the	DT
cord-339444-f8lfob47	13	13	study	study	NN
cord-339444-f8lfob47	13	14	population	population	NN
cord-339444-f8lfob47	13	15	likely	likely	RB
cord-339444-f8lfob47	13	16	represents	represent	VBZ
cord-339444-f8lfob47	13	17	a	a	DT
cord-339444-f8lfob47	13	18	selected	select	VBN
cord-339444-f8lfob47	13	19	group	group	NN
cord-339444-f8lfob47	13	20	of	of	IN
cord-339444-f8lfob47	13	21	individuals	individual	NNS
cord-339444-f8lfob47	13	22	with	with	IN
cord-339444-f8lfob47	13	23	low	low	JJ
cord-339444-f8lfob47	13	24	prevalence	prevalence	NN
cord-339444-f8lfob47	13	25	of	of	IN
cord-339444-f8lfob47	13	26	comorbidities	comorbiditie	NNS
cord-339444-f8lfob47	13	27	known	know	VBN
cord-339444-f8lfob47	13	28	to	to	TO
cord-339444-f8lfob47	13	29	favor	favor	VB
cord-339444-f8lfob47	13	30	the	the	DT
cord-339444-f8lfob47	13	31	occurrence	occurrence	NN
cord-339444-f8lfob47	13	32	of	of	IN
cord-339444-f8lfob47	13	33	hydroxychloroquine	hydroxychloroquine	NN
cord-339444-f8lfob47	13	34	-	-	HYPH
cord-339444-f8lfob47	13	35	related	relate	VBN
cord-339444-f8lfob47	13	36	cardiac	cardiac	JJ
cord-339444-f8lfob47	13	37	adverse	adverse	JJ
cord-339444-f8lfob47	13	38	events	event	NNS
cord-339444-f8lfob47	13	39	.	.	.
cord-339444-f8lfob47	14	1	Moreover	moreover	RB
cord-339444-f8lfob47	14	2	,	,	,
cord-339444-f8lfob47	14	3	the	the	DT
cord-339444-f8lfob47	14	4	multivariable	multivariable	JJ
cord-339444-f8lfob47	14	5	model	model	NN
cord-339444-f8lfob47	14	6	used	use	VBN
cord-339444-f8lfob47	14	7	to	to	TO
cord-339444-f8lfob47	14	8	explore	explore	VB
cord-339444-f8lfob47	14	9	factors	factor	NNS
cord-339444-f8lfob47	14	10	associated	associate	VBN
cord-339444-f8lfob47	14	11	with	with	IN
cord-339444-f8lfob47	14	12	poor	poor	JJ
cord-339444-f8lfob47	14	13	outcomes	outcome	NNS
cord-339444-f8lfob47	14	14	in	in	IN
cord-339444-f8lfob47	14	15	this	this	DT
cord-339444-f8lfob47	14	16	study	study	NN
cord-339444-f8lfob47	14	17	presents	present	VBZ
cord-339444-f8lfob47	14	18	some	some	DT
cord-339444-f8lfob47	14	19	weaknesses	weakness	NNS
cord-339444-f8lfob47	14	20	.	.	.
cord-339444-f8lfob47	15	1	Although	although	IN
cord-339444-f8lfob47	15	2	age	age	NN
cord-339444-f8lfob47	15	3	,	,	,
cord-339444-f8lfob47	15	4	some	some	DT
cord-339444-f8lfob47	15	5	co	co	NNS
cord-339444-f8lfob47	15	6	-	-	NNS
cord-339444-f8lfob47	15	7	medications	medication	NNS
cord-339444-f8lfob47	15	8	,	,	,
cord-339444-f8lfob47	15	9	viral	viral	JJ
cord-339444-f8lfob47	15	10	load	load	NN
cord-339444-f8lfob47	15	11	at	at	IN
cord-339444-f8lfob47	15	12	inclusion	inclusion	NN
cord-339444-f8lfob47	15	13	,	,	,
cord-339444-f8lfob47	15	14	and	and	CC
cord-339444-f8lfob47	15	15	national	national	JJ
cord-339444-f8lfob47	15	16	early	early	JJ
cord-339444-f8lfob47	15	17	warning	warning	NN
cord-339444-f8lfob47	15	18	score	score	NN
cord-339444-f8lfob47	15	19	for	for	IN
cord-339444-f8lfob47	15	20	clinical	clinical	JJ
cord-339444-f8lfob47	15	21	severity	severity	NN
cord-339444-f8lfob47	15	22	were	be	VBD
cord-339444-f8lfob47	15	23	included	include	VBN
cord-339444-f8lfob47	15	24	in	in	IN
cord-339444-f8lfob47	15	25	the	the	DT
cord-339444-f8lfob47	15	26	multivariable	multivariable	JJ
cord-339444-f8lfob47	15	27	model	model	NN
cord-339444-f8lfob47	15	28	,	,	,
cord-339444-f8lfob47	15	29	it	-PRON-	PRP
cord-339444-f8lfob47	15	30	is	be	VBZ
cord-339444-f8lfob47	15	31	surprising	surprising	JJ
cord-339444-f8lfob47	15	32	that	that	IN
cord-339444-f8lfob47	15	33	important	important	JJ
cord-339444-f8lfob47	15	34	factors	factor	NNS
cord-339444-f8lfob47	15	35	such	such	JJ
cord-339444-f8lfob47	15	36	as	as	IN
cord-339444-f8lfob47	15	37	sex	sex	NN
cord-339444-f8lfob47	15	38	and	and	CC
cord-339444-f8lfob47	15	39	chronic	chronic	JJ
cord-339444-f8lfob47	15	40	conditions	condition	NNS
cord-339444-f8lfob47	15	41	were	be	VBD
cord-339444-f8lfob47	15	42	omitted	omit	VBN
cord-339444-f8lfob47	15	43	.	.	.
cord-339444-f8lfob47	16	1	There	there	EX
cord-339444-f8lfob47	16	2	is	be	VBZ
cord-339444-f8lfob47	16	3	evidence	evidence	NN
cord-339444-f8lfob47	16	4	supporting	support	VBG
cord-339444-f8lfob47	16	5	the	the	DT
cord-339444-f8lfob47	16	6	association	association	NNP
cord-339444-f8lfob47	16	7	of	of	IN
cord-339444-f8lfob47	16	8	male	male	NNP
cord-339444-f8lfob47	16	9	sex	sex	NN
cord-339444-f8lfob47	16	10	and	and	CC
cord-339444-f8lfob47	16	11	several	several	JJ
cord-339444-f8lfob47	16	12	chronic	chronic	JJ
cord-339444-f8lfob47	16	13	conditions	condition	NNS
cord-339444-f8lfob47	16	14	,	,	,
cord-339444-f8lfob47	16	15	including	include	VBG
cord-339444-f8lfob47	16	16	those	those	DT
cord-339444-f8lfob47	16	17	reported	report	VBN
cord-339444-f8lfob47	16	18	in	in	IN
cord-339444-f8lfob47	16	19	this	this	DT
cord-339444-f8lfob47	16	20	study	study	NN
cord-339444-f8lfob47	16	21	,	,	,
cord-339444-f8lfob47	16	22	with	with	IN
cord-339444-f8lfob47	16	23	poor	poor	JJ
cord-339444-f8lfob47	16	24	clinical	clinical	JJ
cord-339444-f8lfob47	16	25	outcomes	outcome	NNS
cord-339444-f8lfob47	16	26	[	[	-LRB-
cord-339444-f8lfob47	16	27	3	3	CD
cord-339444-f8lfob47	16	28	]	]	-RRB-
cord-339444-f8lfob47	16	29	.	.	.
cord-339444-f8lfob47	17	1	This	this	DT
cord-339444-f8lfob47	17	2	is	be	VBZ
cord-339444-f8lfob47	17	3	more	more	RBR
cord-339444-f8lfob47	17	4	concerning	concern	VBG
cord-339444-f8lfob47	17	5	in	in	IN
cord-339444-f8lfob47	17	6	view	view	NN
cord-339444-f8lfob47	17	7	of	of	IN
cord-339444-f8lfob47	17	8	the	the	DT
cord-339444-f8lfob47	17	9	significantly	significantly	RB
cord-339444-f8lfob47	17	10	higher	high	JJR
cord-339444-f8lfob47	17	11	prevalence	prevalence	NN
cord-339444-f8lfob47	17	12	of	of	IN
cord-339444-f8lfob47	17	13	chronic	chronic	JJ
cord-339444-f8lfob47	17	14	conditions	condition	NNS
cord-339444-f8lfob47	17	15	in	in	IN
cord-339444-f8lfob47	17	16	patients	patient	NNS
cord-339444-f8lfob47	17	17	with	with	IN
cord-339444-f8lfob47	17	18	poor	poor	JJ
cord-339444-f8lfob47	17	19	clinical	clinical	JJ
cord-339444-f8lfob47	17	20	outcome	outcome	NN
cord-339444-f8lfob47	17	21	in	in	IN
cord-339444-f8lfob47	17	22	this	this	DT
cord-339444-f8lfob47	17	23	study	study	NN
cord-339444-f8lfob47	17	24	.	.	.
cord-339444-f8lfob47	18	1	A	a	DT
cord-339444-f8lfob47	18	2	more	more	RBR
cord-339444-f8lfob47	18	3	effective	effective	JJ
cord-339444-f8lfob47	18	4	handling	handling	NN
cord-339444-f8lfob47	18	5	of	of	IN
cord-339444-f8lfob47	18	6	potential	potential	JJ
cord-339444-f8lfob47	18	7	confounders	confounder	NNS
cord-339444-f8lfob47	18	8	could	could	MD
cord-339444-f8lfob47	18	9	have	have	VB
cord-339444-f8lfob47	18	10	been	be	VBN
cord-339444-f8lfob47	18	11	achieved	achieve	VBN
cord-339444-f8lfob47	18	12	through	through	IN
cord-339444-f8lfob47	18	13	a	a	DT
cord-339444-f8lfob47	18	14	multivariable	multivariable	JJ
cord-339444-f8lfob47	18	15	model	model	NN
cord-339444-f8lfob47	18	16	including	include	VBG
cord-339444-f8lfob47	18	17	all	all	DT
cord-339444-f8lfob47	18	18	known	know	VBN
cord-339444-f8lfob47	18	19	clinically	clinically	RB
cord-339444-f8lfob47	18	20	relevant	relevant	JJ
cord-339444-f8lfob47	18	21	prognostic	prognostic	JJ
cord-339444-f8lfob47	18	22	factors	factor	NNS
cord-339444-f8lfob47	18	23	or	or	CC
cord-339444-f8lfob47	18	24	the	the	DT
cord-339444-f8lfob47	18	25	use	use	NN
cord-339444-f8lfob47	18	26	of	of	IN
cord-339444-f8lfob47	18	27	propensity	propensity	NN
cord-339444-f8lfob47	18	28	score	score	NN
cord-339444-f8lfob47	18	29	matching	matching	NN
cord-339444-f8lfob47	18	30	.	.	.
cord-339444-f8lfob47	19	1	Finally	finally	RB
cord-339444-f8lfob47	19	2	,	,	,
cord-339444-f8lfob47	19	3	due	due	IN
cord-339444-f8lfob47	19	4	to	to	IN
cord-339444-f8lfob47	19	5	the	the	DT
cord-339444-f8lfob47	19	6	retrospective	retrospective	JJ
cord-339444-f8lfob47	19	7	nature	nature	NN
cord-339444-f8lfob47	19	8	of	of	IN
cord-339444-f8lfob47	19	9	the	the	DT
cord-339444-f8lfob47	19	10	study	study	NN
cord-339444-f8lfob47	19	11	,	,	,
cord-339444-f8lfob47	19	12	it	-PRON-	PRP
cord-339444-f8lfob47	19	13	was	be	VBD
cord-339444-f8lfob47	19	14	not	not	RB
cord-339444-f8lfob47	19	15	possible	possible	JJ
cord-339444-f8lfob47	19	16	to	to	TO
cord-339444-f8lfob47	19	17	consider	consider	VB
cord-339444-f8lfob47	19	18	blinding	blind	VBG
cord-339444-f8lfob47	19	19	for	for	IN
cord-339444-f8lfob47	19	20	outcome	outcome	NN
cord-339444-f8lfob47	19	21	assessment	assessment	NN
cord-339444-f8lfob47	19	22	.	.	.
cord-339444-f8lfob47	20	1	Except	except	IN
cord-339444-f8lfob47	20	2	for	for	IN
cord-339444-f8lfob47	20	3	death	death	NN
cord-339444-f8lfob47	20	4	,	,	,
cord-339444-f8lfob47	20	5	clinical	clinical	JJ
cord-339444-f8lfob47	20	6	outcomes	outcome	NNS
cord-339444-f8lfob47	20	7	such	such	JJ
cord-339444-f8lfob47	20	8	as	as	IN
cord-339444-f8lfob47	20	9	transfer	transfer	NN
cord-339444-f8lfob47	20	10	to	to	IN
cord-339444-f8lfob47	20	11	intensive	intensive	JJ
cord-339444-f8lfob47	20	12	care	care	NN
cord-339444-f8lfob47	20	13	unit	unit	NN
cord-339444-f8lfob47	20	14	(	(	-LRB-
cord-339444-f8lfob47	20	15	ICU	ICU	NNP
cord-339444-f8lfob47	20	16	)	)	-RRB-
cord-339444-f8lfob47	20	17	or	or	CC
cord-339444-f8lfob47	20	18	hospitalization	hospitalization	NN
cord-339444-f8lfob47	20	19	for	for	IN
cord-339444-f8lfob47	20	20	ten	ten	CD
cord-339444-f8lfob47	20	21	days	day	NNS
cord-339444-f8lfob47	20	22	may	may	MD
cord-339444-f8lfob47	20	23	vary	vary	VB
cord-339444-f8lfob47	20	24	across	across	IN
cord-339444-f8lfob47	20	25	physicians	physician	NNS
cord-339444-f8lfob47	20	26	.	.	.
cord-339444-f8lfob47	21	1	For	for	IN
cord-339444-f8lfob47	21	2	example	example	NN
cord-339444-f8lfob47	21	3	,	,	,
cord-339444-f8lfob47	21	4	J	J	NNP
cord-339444-f8lfob47	21	5	o	o	NN
cord-339444-f8lfob47	21	6	u	u	NN
cord-339444-f8lfob47	21	7	r	r	NN
cord-339444-f8lfob47	21	8	n	n	NN
cord-339444-f8lfob47	21	9	a	a	DT
cord-339444-f8lfob47	21	10	l	l	NN
cord-339444-f8lfob47	21	11	P	p	NN
cord-339444-f8lfob47	21	12	r	r	NN
cord-339444-f8lfob47	21	13	e	e	NN
cord-339444-f8lfob47	21	14	-p	-p	NN
cord-339444-f8lfob47	21	15	r	r	NN
cord-339444-f8lfob47	22	1	o	o	UH
cord-339444-f8lfob47	22	2	o	o	NN
cord-339444-f8lfob47	22	3	f	f	NN
cord-339444-f8lfob47	22	4	physicians	physician	NNS
cord-339444-f8lfob47	22	5	may	may	MD
cord-339444-f8lfob47	22	6	have	have	VB
cord-339444-f8lfob47	22	7	a	a	DT
cord-339444-f8lfob47	22	8	higher	high	JJR
cord-339444-f8lfob47	22	9	tendency	tendency	NN
cord-339444-f8lfob47	22	10	to	to	TO
cord-339444-f8lfob47	22	11	keep	keep	VB
cord-339444-f8lfob47	22	12	patients	patient	NNS
cord-339444-f8lfob47	22	13	with	with	IN
cord-339444-f8lfob47	22	14	chronic	chronic	JJ
cord-339444-f8lfob47	22	15	co	co	NNS
cord-339444-f8lfob47	22	16	-	-	NNS
cord-339444-f8lfob47	22	17	morbidities	morbidity	NNS
cord-339444-f8lfob47	22	18	longer	longer	RB
cord-339444-f8lfob47	22	19	in	in	IN
cord-339444-f8lfob47	22	20	hospital	hospital	NN
cord-339444-f8lfob47	22	21	or	or	CC
cord-339444-f8lfob47	22	22	to	to	TO
cord-339444-f8lfob47	22	23	transfer	transfer	VB
cord-339444-f8lfob47	22	24	them	-PRON-	PRP
cord-339444-f8lfob47	22	25	to	to	IN
cord-339444-f8lfob47	22	26	ICU	ICU	NNP
cord-339444-f8lfob47	22	27	.	.	.
cord-339444-f8lfob47	23	1	It	-PRON-	PRP
cord-339444-f8lfob47	23	2	is	be	VBZ
cord-339444-f8lfob47	23	3	worth	worth	JJ
cord-339444-f8lfob47	23	4	noting	note	VBG
cord-339444-f8lfob47	23	5	that	that	IN
cord-339444-f8lfob47	23	6	the	the	DT
cord-339444-f8lfob47	23	7	discussion	discussion	NN
cord-339444-f8lfob47	23	8	of	of	IN
cord-339444-f8lfob47	23	9	the	the	DT
cord-339444-f8lfob47	23	10	study	study	NN
cord-339444-f8lfob47	23	11	limitations	limitation	NNS
cord-339444-f8lfob47	23	12	is	be	VBZ
cord-339444-f8lfob47	23	13	focused	focus	VBN
cord-339444-f8lfob47	23	14	on	on	IN
cord-339444-f8lfob47	23	15	the	the	DT
cord-339444-f8lfob47	23	16	explanation	explanation	NN
cord-339444-f8lfob47	23	17	of	of	IN
cord-339444-f8lfob47	23	18	missing	miss	VBG
cord-339444-f8lfob47	23	19	data	datum	NNS
cord-339444-f8lfob47	23	20	without	without	IN
cord-339444-f8lfob47	23	21	highlighting	highlight	VBG
cord-339444-f8lfob47	23	22	the	the	DT
cord-339444-f8lfob47	23	23	methodological	methodological	JJ
cord-339444-f8lfob47	23	24	concerns	concern	NNS
cord-339444-f8lfob47	23	25	.	.	.
cord-339444-f8lfob47	24	1	In	in	IN
cord-339444-f8lfob47	24	2	conclusion	conclusion	NN
cord-339444-f8lfob47	24	3	,	,	,
cord-339444-f8lfob47	24	4	given	give	VBN
cord-339444-f8lfob47	24	5	the	the	DT
cord-339444-f8lfob47	24	6	many	many	JJ
cord-339444-f8lfob47	24	7	limitations	limitation	NNS
cord-339444-f8lfob47	24	8	raised	raise	VBN
cord-339444-f8lfob47	24	9	above	above	RB
cord-339444-f8lfob47	24	10	,	,	,
cord-339444-f8lfob47	24	11	it	-PRON-	PRP
cord-339444-f8lfob47	24	12	is	be	VBZ
cord-339444-f8lfob47	24	13	advisable	advisable	JJ
cord-339444-f8lfob47	24	14	to	to	TO
cord-339444-f8lfob47	24	15	be	be	VB
cord-339444-f8lfob47	24	16	more	more	RBR
cord-339444-f8lfob47	24	17	careful	careful	JJ
cord-339444-f8lfob47	24	18	about	about	IN
cord-339444-f8lfob47	24	19	claims	claim	NNS
cord-339444-f8lfob47	24	20	of	of	IN
cord-339444-f8lfob47	24	21	association	association	NN
cord-339444-f8lfob47	24	22	between	between	IN
cord-339444-f8lfob47	24	23	HCQ+AZ	HCQ+AZ	NNP
cord-339444-f8lfob47	24	24	and	and	CC
cord-339444-f8lfob47	24	25	low	low	JJ
cord-339444-f8lfob47	24	26	fatality	fatality	NN
cord-339444-f8lfob47	24	27	rates	rate	NNS
cord-339444-f8lfob47	24	28	,	,	,
cord-339444-f8lfob47	24	29	especially	especially	RB
cord-339444-f8lfob47	24	30	when	when	WRB
cord-339444-f8lfob47	24	31	considering	consider	VBG
cord-339444-f8lfob47	24	32	the	the	DT
cord-339444-f8lfob47	24	33	latest	late	JJS
cord-339444-f8lfob47	24	34	evidence	evidence	NN
cord-339444-f8lfob47	24	35	from	from	IN
cord-339444-f8lfob47	24	36	a	a	DT
cord-339444-f8lfob47	24	37	randomized	randomized	JJ
cord-339444-f8lfob47	24	38	controlled	control	VBN
cord-339444-f8lfob47	24	39	trial	trial	NN
cord-339444-f8lfob47	24	40	of	of	IN
cord-339444-f8lfob47	24	41	HCQ	HCQ	NNP
cord-339444-f8lfob47	24	42	as	as	IN
cord-339444-f8lfob47	24	43	postexposure	postexposure	NN
cord-339444-f8lfob47	24	44	prophylaxis	prophylaxis	NN
cord-339444-f8lfob47	24	45	where	where	WRB
cord-339444-f8lfob47	24	46	HCQ	HCQ	NNP
cord-339444-f8lfob47	24	47	did	do	VBD
cord-339444-f8lfob47	24	48	not	not	RB
cord-339444-f8lfob47	24	49	prevent	prevent	VB
cord-339444-f8lfob47	24	50	illness	illness	NN
cord-339444-f8lfob47	24	51	compatible	compatible	JJ
cord-339444-f8lfob47	24	52	with	with	IN
cord-339444-f8lfob47	24	53	COVID-19	COVID-19	NNP
cord-339444-f8lfob47	24	54	or	or	CC
cord-339444-f8lfob47	24	55	confirmed	confirm	VBN
cord-339444-f8lfob47	24	56	infection	infection	NN
cord-339444-f8lfob47	24	57	[	[	-LRB-
cord-339444-f8lfob47	24	58	4	4	CD
cord-339444-f8lfob47	24	59	]	]	-RRB-
cord-339444-f8lfob47	24	60	.	.	.
cord-339444-f8lfob47	25	1	In	in	IN
cord-339444-f8lfob47	25	2	addition	addition	NN
cord-339444-f8lfob47	25	3	,	,	,
cord-339444-f8lfob47	25	4	recommendations	recommendation	NNS
cord-339444-f8lfob47	25	5	for	for	IN
cord-339444-f8lfob47	25	6	a	a	DT
cord-339444-f8lfob47	25	7	universal	universal	JJ
cord-339444-f8lfob47	25	8	test	test	NN
cord-339444-f8lfob47	25	9	-	-	HYPH
cord-339444-f8lfob47	25	10	and	and	CC
cord-339444-f8lfob47	25	11	-	-	HYPH
cord-339444-f8lfob47	25	12	treat	treat	VB
cord-339444-f8lfob47	25	13	strategy	strategy	NN
cord-339444-f8lfob47	25	14	made	make	VBN
cord-339444-f8lfob47	25	15	by	by	IN
cord-339444-f8lfob47	25	16	the	the	DT
cord-339444-f8lfob47	25	17	authors	author	NNS
cord-339444-f8lfob47	25	18	should	should	MD
cord-339444-f8lfob47	25	19	be	be	VB
cord-339444-f8lfob47	25	20	tempered	temper	VBN
cord-339444-f8lfob47	25	21	since	since	IN
cord-339444-f8lfob47	25	22	this	this	DT
cord-339444-f8lfob47	25	23	was	be	VBD
cord-339444-f8lfob47	25	24	not	not	RB
cord-339444-f8lfob47	25	25	studied	study	VBN
cord-339444-f8lfob47	25	26	.	.	.
cord-339444-f8lfob47	26	1	Early	early	JJ
cord-339444-f8lfob47	26	2	treatment	treatment	NN
cord-339444-f8lfob47	26	3	of	of	IN
cord-339444-f8lfob47	26	4	COVID-19	covid-19	JJ
cord-339444-f8lfob47	26	5	patients	patient	NNS
cord-339444-f8lfob47	26	6	with	with	IN
cord-339444-f8lfob47	26	7	hydroxychloroquine	hydroxychloroquine	NN
cord-339444-f8lfob47	26	8	and	and	CC
cord-339444-f8lfob47	26	9	azithromycin	azithromycin	NNP
cord-339444-f8lfob47	26	10	:	:	:
cord-339444-f8lfob47	26	11	A	a	DT
cord-339444-f8lfob47	26	12	retrospective	retrospective	JJ
cord-339444-f8lfob47	26	13	analysis	analysis	NN
cord-339444-f8lfob47	26	14	of	of	IN
cord-339444-f8lfob47	26	15	1061	1061	CD
cord-339444-f8lfob47	26	16	cases	case	NNS
cord-339444-f8lfob47	26	17	in	in	IN
cord-339444-f8lfob47	26	18	Marseille	Marseille	NNP
cord-339444-f8lfob47	26	19	,	,	,
cord-339444-f8lfob47	26	20	France	France	NNP
cord-339444-f8lfob47	26	21	.	.	.
cord-339444-f8lfob47	27	1	Travel	travel	NN
cord-339444-f8lfob47	27	2	medicine	medicine	NN
cord-339444-f8lfob47	27	3	and	and	CC
cord-339444-f8lfob47	27	4	infectious	infectious	JJ
cord-339444-f8lfob47	27	5	disease	disease	NN
cord-339444-f8lfob47	27	6	Factors	factor	NNS
cord-339444-f8lfob47	27	7	associated	associate	VBN
cord-339444-f8lfob47	27	8	with	with	IN
cord-339444-f8lfob47	27	9	hospital	hospital	NN
cord-339444-f8lfob47	27	10	admission	admission	NN
cord-339444-f8lfob47	27	11	and	and	CC
cord-339444-f8lfob47	27	12	critical	critical	JJ
cord-339444-f8lfob47	27	13	illness	illness	NN
cord-339444-f8lfob47	27	14	among	among	IN
cord-339444-f8lfob47	27	15	5279	5279	CD
cord-339444-f8lfob47	27	16	people	people	NNS
cord-339444-f8lfob47	27	17	with	with	IN
cord-339444-f8lfob47	27	18	coronavirus	coronavirus	NN
cord-339444-f8lfob47	27	19	disease	disease	NN
cord-339444-f8lfob47	27	20	Risk	risk	NN
cord-339444-f8lfob47	27	21	factors	factor	NNS
cord-339444-f8lfob47	27	22	of	of	IN
cord-339444-f8lfob47	27	23	critical	critical	JJ
cord-339444-f8lfob47	27	24	&	&	CC
cord-339444-f8lfob47	27	25	mortal	mortal	JJ
cord-339444-f8lfob47	27	26	COVID-19	COVID-19	NNP
cord-339444-f8lfob47	27	27	cases	case	NNS
cord-339444-f8lfob47	27	28	:	:	:
cord-339444-f8lfob47	27	29	A	a	DT
cord-339444-f8lfob47	27	30	systematic	systematic	JJ
cord-339444-f8lfob47	27	31	literature	literature	NN
cord-339444-f8lfob47	27	32	review	review	NN
cord-339444-f8lfob47	27	33	and	and	CC
cord-339444-f8lfob47	27	34	meta	meta	NNP
cord-339444-f8lfob47	27	35	-	-	HYPH
cord-339444-f8lfob47	27	36	analysis	analysis	NN
cord-339444-f8lfob47	27	37	A	A	NNP
cord-339444-f8lfob47	27	38	Randomized	Randomized	NNP
cord-339444-f8lfob47	27	39	Trial	Trial	NNP
cord-339444-f8lfob47	27	40	of	of	IN
cord-339444-f8lfob47	27	41	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-339444-f8lfob47	27	42	as	as	IN
cord-339444-f8lfob47	27	43	Postexposure	Postexposure	NNP
cord-339444-f8lfob47	27	44	Prophylaxis	Prophylaxis	NNP
cord-339444-f8lfob47	27	45	for	for	IN
cord-339444-f8lfob47	27	46	Covid-19	covid-19	NN
cord-339444-f8lfob47	27	47	.	.	.
cord-339444-f8lfob47	28	1	The	the	DT
cord-339444-f8lfob47	28	2	New	New	NNP
cord-339444-f8lfob47	28	3	England	England	NNP
cord-339444-f8lfob47	28	4	journal	journal	NN
cord-339444-f8lfob47	28	5	of	of	IN
cord-339444-f8lfob47	28	6	medicine	medicine	NNP
cord-339444-f8lfob47	29	1	All	all	DT
cord-339444-f8lfob47	29	2	authors	author	NNS
cord-339444-f8lfob47	29	3	contributed	contribute	VBD
cord-339444-f8lfob47	29	4	to	to	IN
cord-339444-f8lfob47	29	5	writing	write	VBG
cord-339444-f8lfob47	29	6	this	this	DT
cord-339444-f8lfob47	29	7	article	article	NN
cord-339444-f8lfob47	29	8	and	and	CC
cord-339444-f8lfob47	29	9	approved	approve	VBD
cord-339444-f8lfob47	29	10	its	-PRON-	PRP$
cord-339444-f8lfob47	29	11	final	final	JJ
cord-339444-f8lfob47	29	12	version	version	NN
cord-339444-f8lfob47	29	13	.	.	.
cord-339444-f8lfob47	30	1	There	there	EX
cord-339444-f8lfob47	30	2	is	be	VBZ
cord-339444-f8lfob47	30	3	no	no	DT
cord-339444-f8lfob47	30	4	funding	funding	NN
cord-339444-f8lfob47	30	5	source	source	NN
cord-339444-f8lfob47	30	6	used	use	VBN
cord-339444-f8lfob47	30	7	for	for	IN
cord-339444-f8lfob47	30	8	this	this	DT
cord-339444-f8lfob47	30	9	paper	paper	NN
cord-339444-f8lfob47	30	10	.	.	.
cord-339444-f8lfob47	31	1	There	there	EX
cord-339444-f8lfob47	31	2	is	be	VBZ
cord-339444-f8lfob47	31	3	no	no	DT
cord-339444-f8lfob47	31	4	competing	compete	VBG
cord-339444-f8lfob47	31	5	interest	interest	NN
cord-339444-f8lfob47	31	6	.	.	.